Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Net Income (2020 - 2025)

Historic Net Income for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to -$1.2 million.

  • Evoke Pharma's Net Income rose 1190.06% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year increase of 1497.85%. This contributed to the annual value of -$5.4 million for FY2024, which is 3131.43% up from last year.
  • According to the latest figures from Q3 2025, Evoke Pharma's Net Income is -$1.2 million, which was up 1190.06% from -$1.6 million recorded in Q2 2025.
  • Evoke Pharma's 5-year Net Income high stood at -$1.2 million for Q3 2025, and its period low was -$2.7 million during Q1 2021.
  • Moreover, its 5-year median value for Net Income was -$1.8 million (2022), whereas its average is -$1.8 million.
  • Per our database at Business Quant, Evoke Pharma's Net Income skyrocketed by 6712.34% in 2021 and then tumbled by 2397.05% in 2025.
  • Evoke Pharma's Net Income (Quarter) stood at -$1.7 million in 2021, then fell by 7.82% to -$1.8 million in 2022, then dropped by 10.21% to -$2.0 million in 2023, then skyrocketed by 39.98% to -$1.2 million in 2024, then increased by 3.06% to -$1.2 million in 2025.
  • Its Net Income stands at -$1.2 million for Q3 2025, versus -$1.6 million for Q2 2025 and -$1.3 million for Q1 2025.